menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Endo Launches Doxycycline for Injection, USP

    PR NEWSWIRE

    Alembic`s Generic Doxycycline Receives Approval in US

    FDA

    To protect against STIs, CDC recommends antibiotic doxycycline

    FIERCE PHARMA

    Dr. Reddy`s launches Doxycycline Capsules, 40 mg in US

    PRESS RELEASE

    Lupin`s Generic Doxycycline Receives Approval in the U.S.

    FDA

    Dr Reddys Labs` Generic Doxycycline Receives Approval in the U.S

    FDA

    Doxycycline prevents acquisition of sexually transmitted infections in trial

    CLINICAL TRIALS ARENA

    Lupin`s Generic Doxycycline Receives Approval in the U.S.

    FDA

    Doxycycline After Unprotected Sex Significantly Reduced STIs

    UCSF.EDU

    Elite Pharma and Praxgen Pharma Receive FDA Approval for Generic Doxycycline

    ACCESSWIRE

    DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®

    NEWSWIRE

    Azithromycin, doxycycline not effective in early-stage COVID-19 - study

    REUTERS

    Australian researcher shares Low-Dose Ivermectin Therapy protocol for COVID-19

    BIOSPECTRUM

    Fusion Health Care launches favipiravir for COVID-19 treatment

    EXPRESSPHARMA

    Expiration date extensions of certain lots of doxycycline hyclate capsules

    FDA

    Zydus receives USFDA SANDA approval for Doxycycline Injection

    BUSINESSSTANDARD

    Zydus Cadila gets USFDA nod for manufacturing Doxycycline Injection at Vadodar

    ECONOMICTIMES

    NIH-funded research leads to pediatric labeling updates for doxycycline

    NIH

    Enforcement Report - Week of March 25, 2020

    FDA

    Govt panel lists essential medicines that may run out of stock: Report

    MONEYCONTROL

    Hovione Announces Phase 3 Program for Minocycline Meeting the FDA & Outlines

    PR NEWSWIRE

    Generic Drugmaker Admits to Price Fixing

    RAPS

    Sweeping lawsuit accuses top generic drug companies, executives of fixing prices

    CBSNEWS

    Amneal Pharm`s Generic Doxycycline Receives Tentative Approval in US

    FDA

    Investigation of generic ‘cartel’ expands to 300 drugs

    WASHINGTON POST

    Oracea (doxycycline) : Galderma Labs vs. Sun Pharmaceutical Industries

    PATENT LITIGATION

    Drugs, disinfectants in short supply in relief camps

    ECONOMIC TIMES

    Amneal Pharms`s Generic Doxycycline Receives Tentative Approval in US

    FDA

    Mayne pharma launches generic version of Monodox in Australia

    BIOSPECTRUM

    Alembic Pharm’s Generic Doxycycline Receives Approval In US

    FDA

    Enforcement Report - Week of June 21, 2017

    FDA

    Golfing, ‘girls night out’ where pharma employees allegedly fixed prices

    STAT

    Price Fixing Lawsuit Slapped Against Aurobindo, Mylan, Others in US

    FINANCIAL EXPRESS

    DOJ`s price-fixing investigation could lead to sizable liabilities, analyst says

    FIERCE PHARMA

    Hillary Clinton win may pose pricing challenges for Indian pharma companies

    ECONOMIC TIMES

    Lupin divest two products to G&W Laboratories at behest of USFTC – A Closer Look

    TWOFOUR INSIGHT

    Zydus Cadila’s Ahmedabad SEZ Unit Goes Online with Generic Monodox

    TWOFOUR INSIGHT

    Zydus Pharms Usa`s Generic Doxycycline approved in US to treat bacterial infections

    FDA

    FDA approvals to boost Dr. Reddy`s prospects in US: Nomura

    BUSINESS STANDARD

    Amneal Pharm`s Generic Doxycycline tentatively approved in US for treating bacterial infections

    FDA

    Dr Reddy`s Zenavod (Doxycycline) approved in US for treatment of bacterial infections

    FDA

    US FTC: `Product-hopping` illegally impedes generic entry

    IN-PHARMA TECHNOLOGIST

    Anvisa suspends all lots of antibiotic Protectin

    ANVISA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Millions To Be Made On...Generic Drugs?

    FORBES

    Hikma Profits Soften as Shortages of Doxycycline are Resolved

    FIERCE PHARMA MFG.

    Why Are Some Generic Drugs Getting So Expensive?

    IFL SCIENCE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.